BridgeMD
New treatment option for Perceptual Disorders
Official title Standardization of Spatial Neglect Assessment Tests
ClinicalTrials.gov ID: NCT07145970
What this study is testing
- What it's testing
- Spatial neglect is a common cognitive disorder in stroke patients, characterized by a lateralized deficit in attention and intention. This research focuses on defining norms for tests to assess spatial neglect.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 89. Healthy volunteers may be eligible.
You may be able to join if
- Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
- Aged between 20 and 89 years
- Affiliated with a health insurance scheme
- French-speaking
- Has freely and knowingly expressed their non-opposition
You likely can't join if
- Known history of central neurological disease: stroke (ischemic or hemorrhagic), transient ischemic attack, encephalitis, multiple sclerosis, or...
- Medical interview suggesting past central nervous system involvement: history of episodes such as sensorimotor deficits, dysarthria, aphasia, blurred...
- Significant visual impairment - as judged by the examiner - in near vision despite correction, or monocular blindness. Specifically, inability to...
- Abnormal neurological examination:
- National Institutes of Health Stroke Scale (NIHSS) score \> 0
- Pyramidal reflex syndrome (hyperactive deep tendon reflexes with extended reflexogenic zones and spread).
See the full eligibility criteria
- Healthy volunteer attending the neurovascular department of Raymond-Poincaré Hospital
- Aged between 20 and 89 years
- Affiliated with a health insurance scheme
- French-speaking
- Has freely and knowingly expressed their non-opposition
- Known history of central neurological disease: stroke (ischemic or hemorrhagic), transient ischemic attack, encephalitis, multiple sclerosis, or epilepsy.
- Medical interview suggesting past central nervous system involvement: history of episodes such as sensorimotor deficits, dysarthria, aphasia, blurred or double vision, or positive symptoms such as visual or sensory...
- Significant visual impairment - as judged by the examiner - in near vision despite correction, or monocular blindness. Specifically, inability to distinguish the targets with gaps in the example (pre-test) of the Apples...
- Abnormal neurological examination:
- National Institutes of Health Stroke Scale (NIHSS) score \> 0
- Pyramidal reflex syndrome (hyperactive deep tendon reflexes with extended reflexogenic zones and spread).
- Use of substances (alcohol or drugs) within 24 hours prior to the assessment.
- Presence of cognitive or psychiatric disorders, assessed during the inclusion interview and neurological examination, at the examiner's discretion.
- Language barrier or aphasia, assessed during the inclusion interview and neurological examination, at the examiner's discretion.
- Participant under legal protection (guardianship, curatorship, or legal safeguard).
The study team makes the final eligibility decision.
Where it's taking place
- Garche, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 89 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Garche, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.